Skip to main content
. 2020 Nov 3;10:18924. doi: 10.1038/s41598-020-76033-1

Figure 6.

Figure 6

POLD1R689W-mediated sensitization of DLD-1 cells to the ATR inhibitor AZD6738 in vivo. (A) Schematic representation of the experimental procedure. For clarity, the datasets illustrating vehicle- and AZD6738-treated POLD1+/+ tumors (B, lower left panel) as well as vehicle- and AZD6738-treated POLD1R689W/- tumors (B, lower right panel) are displayed separately. Error bars represent mean ± SEM of eight (vehicle-treated POLD1R689W/- tumors) or nine mice (vehicle-treated POLD1+/+ tumors, AZD6738-treated POLD1+/+ tumors, and AZD6738-treated POLD1R689W/- tumors), respectively.